Integrin profile of circulating tumour cells in breast cancer patients

Background. Integrins, as adhesion molecules, play a key role in the interaction of cells with the basal membrane and intercellular matrix. Numerous studies demonstrate evidence of increased expression of integrins on tumor cells in different types of cancer. Thus, β3 and αV integrins are associated...

Full description

Bibliographic Details
Main Authors:	E. S. Grigoryeva, L. A. Tashireva, V. V. Alifanov, M. V. Zavyalova, V. M. Perelmuter
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2024-09-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer circulating tumor cells integrins neoadjuvant chemotherapy
Online Access:	https://www.siboncoj.ru/jour/article/view/3195

Similar Items

Integrin-associated transcriptional characteristics of circulating tumor cells in breast cancer patients
by: Evgeniya Grigoryeva, et al.
Published: (2024-01-01)

Signs of apoptosis in circulating tumor cell subpopulations with phenotypes associated with stemness and epithelial-mesenchymal transition in breast carcinoma
by: V. M. Perelmuter, et al.
Published: (2022-12-01)

Association of integrin expression in tumor tissue with hematogenic metastasis of breast cancer
by: M. V. Zavyalova, et al.
Published: (2024-01-01)

Pathogenetic and clinical signifcance of EpCАM expression features in tumors and circulating tumor cells
by: V. M. Perelmuter, et al.
Published: (2024-11-01)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
by: Perelmuter VM, et al.
Published: (2019-07-01)

Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
by: Wataru Goto, et al.
Published: (2017-05-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)

Increased Stromal Infiltrating Lymphocytes are Associated with Circulating Tumor Cells and Metastatic Relapse in Breast Cancer Patients After Neoadjuvant Chemotherapy
by: Liu J, et al.
Published: (2019-12-01)

Integrin α6 β4 on circulating tumor cells of metastatic breast cancer patients
by: Mehran Sharifi, et al.
Published: (2021-01-01)

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment
by: V. O. Bashlyk, et al.
Published: (2018-07-01)

Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer
by: Evgeniya V. Kaigorodova, et al.
Published: (2018-03-01)

Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery
by: Wu ZJ, et al.
Published: (2018-09-01)

Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy
by: Li M, et al.
Published: (2024-11-01)

LIMCH1 protein expression associated with lymph node metastasis in breast cancer
by: V. V. Alifanov, et al.
Published: (2023-02-01)

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
by: Sarah Talamantes, et al.
Published: (2020-10-01)

Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
by: Zhuo Zhang, et al.
Published: (2021-12-01)

Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
by: Alba Rodríguez-Martínez, et al.
Published: (2019-02-01)

Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
by: Bouzón Alberto, et al.
Published: (2016-02-01)

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer
by: Meng Zhang, et al.
Published: (2023-09-01)

Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy
by: Lisa König, et al.
Published: (2018-01-01)

Study of feasibility and efficacy of neoadjuvant chemotherapy in cases of locally advanced breast cancer
by: Arun V Dawle, et al.
Published: (2015-01-01)

Invasive lobular carcinoma of the breast; clinicopathologic profile and response to neoadjuvant chemotherapy over a 15-year period
by: N.P. Quirke, et al.
Published: (2024-08-01)

Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis
by: Shuyi Niu, et al.
Published: (2025-01-01)

The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
by: Yaling Wang, et al.
Published: (2020-01-01)

Subpopulation composition of PD-L1-positive lymphocytes in the primary tumour in luminal breast cancer patients
by: L. A. Tashireva, et al.
Published: (2024-07-01)

The features of tumor niche cell composition in invasive breast ductal carcinoma of no special type
by: A. V. Buzenkova, et al.
Published: (2022-11-01)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01)

Study of Tumour Cellularity in Locally Advanced Breast Carcinoma on Neo-Adjuvant Chemotherapy
by: Swarup Kumar, et al.
Published: (2014-04-01)

Definite Treatment Delay With Neoadjuvant Chemotherapy and Longitudinal Monitoring by Circulating Tumor DNA for Advanced Cervical Cancer During Pregnancy: A Case Series and Literature Review
by: Xiaoyu Zhang, et al.
Published: (2024-11-01)

Circulating tumor cells in breast cancer: clinical and molecular parallels
by: A. V. Zyuzyukina, et al.
Published: (2021-09-01)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
by: Po-Han Lin, et al.
Published: (2021-11-01)

BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
by: A. R. Bosieva, et al.
Published: (2021-08-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients
by: Mijia Wang, et al.
Published: (2024-03-01)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
by: Jin Wu, et al.
Published: (2022-10-01)

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01)

CXCR4 EXPRESSION IN DIFFERENT SUBSETS OF CTCs AND SINGLE (DETACHED) BREAST CANCER CELLS
by: O. E. Savelieva, et al.
Published: (2018-09-01)

Expression levels of β1, β3 integrins and MMP2 and features of morphological heterogeneity of pancreatic ductal adenocarcinoma associated with distant metastasis
by: Yu. Yu. Rakina, et al.
Published: (2023-05-01)

THE INFLAMMATORY STATUS AND LYMPH NODE METASTASES IN NON-SMALL CELL LUNG CANCER
by: D. S. Pismenny, et al.
Published: (2020-07-01)